CAS RN: 874013-62-4

Bis{[1-(2R,5R)-2,5-dimethylphospholanyl]-[2-(2R,5R)-2,5-dimethylphospholanyl-1-oxide]benzene}copper(I) trifluoromethanesulfonate, min. 97%

Product Availability

Choose a grade to view its available package options.

5 package records3 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250510 100mg In stock Shanghai Inquiry
Batchno.20250522 1g Out of stock Inquiry
Batchno.20250705 250mg In stock Shanghai Inquiry
Batchno.20251230 50mg In stock Shanghai Inquiry
Batchno.20251103 50mg / 100mg / 250mg Out of stock 8-10 business days Inquiry
  • Product code: starshine_CAS874013-62-4
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

874013-62-4 / copper(1+);bis((2R,5R)-1-[2-[(2R,5R)-2,5-dimethylphospholan-1-yl]phenyl]-2,5-dimethyl-1lambda5-phospholane 1-oxide);trifluoromethanesulfonate

Standard CAS: 874013-62-4 Multi CAS: Yes

Basic Information

CAS
874013-62-4
Multi CAS
Yes
Molecular Formula
C38F3H56O5P4SU
Molecular Weight
857.300000
Exact Mass
856.204701
InChI
InChI=1S/2C18H28OP2.CHF3O3S.Cu/c2*1-13-9-10-14(2)20(13)17-7-5-6-8-18(17)21(19)15(3)11-12-16(21)4;2-1(3,4)8(5,6)7;/h2*5-8,13-16H,9-12H2,1-4H3;(H,5,6,7);/q;;;+1/p-1/t2*13-,14-,15-,16-;;/m11../s1
InChIKey
JGVWSKIVCRMXGT-YCIFJGFLSA-M

Computed Properties

Structural Parameters

Heavy atom count
51
Aromatic heavy atom count
12
Fraction Csp3
0.68
Rotatable bonds
4
H-bond acceptors
5
Molar refractivity
208.86
TPSA
91.34

LogP / Solubility

WLOGP
9.9
MLOGP
8.79
XLogP3
9.9
Consensus LogP
9.53
Log S (ESOL)
-11.3
Class (ESOL)
Insoluble
Log S (Ali)
-13.74
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-13.93
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-0.92

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
9.5

Get In Touch

Contact Us